129 related articles for article (PubMed ID: 1385453)
21. The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.
Barr LF; Campbell SE; Tamez P; Casero RA
Clin Cancer Res; 1998 Jun; 4(6):1557-61. PubMed ID: 9626477
[TBL] [Abstract][Full Text] [Related]
22. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
Kohl NE; Ruley HE
Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
[TBL] [Abstract][Full Text] [Related]
23. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells.
Tsurusaki Y; Yamaguchi M
J Cell Biochem; 2003 Oct; 90(3):619-26. PubMed ID: 14523995
[TBL] [Abstract][Full Text] [Related]
25. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
26. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of proto-oncogene induction from growth response in normal human fibroblasts.
Yaar M; Peacocke M; Cohen MS; Gilchrest BA
J Cell Physiol; 1990 Oct; 145(1):39-45. PubMed ID: 2120243
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cell growth and the c-myc proto-oncogene expression by phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA) in the androgen-independent human prostatic JCA-1 cells.
Wang XH; Whyzmuzis CA; An S; Chen Y; Wu JM; Schneidau TA; Mallouh C; Tazaki H
Biochem Mol Biol Int; 1994 Aug; 34(1):47-53. PubMed ID: 7849624
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
Trojanowska M; Wu LT; LeRoy EC
Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
[TBL] [Abstract][Full Text] [Related]
31. Effects of mutationally activated Ha-ras on c-fos expression kinetics in rat tracheal epithelial cells.
Hubbard FC; Cosma G; Garte SJ
Mol Carcinog; 1996 Jun; 16(2):77-82. PubMed ID: 8645429
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
33. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle dependent growth factor regulation of gene expression.
Morgan CJ; Pledger WJ
J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
[TBL] [Abstract][Full Text] [Related]
35. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
[TBL] [Abstract][Full Text] [Related]
36. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
Longstreet M; Miller B; Howe PH
Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
[TBL] [Abstract][Full Text] [Related]
37. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
Habel ME; Lemieux R; Jung D
J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
[TBL] [Abstract][Full Text] [Related]
38. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
39. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
Futscher BW; Erickson LC
Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
[TBL] [Abstract][Full Text] [Related]
40. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells.
Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC
Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
